Featured Research

from universities, journals, and other organizations

Scientists Study Genes To Improve Warfarin Treatment

Date:
February 20, 2009
Source:
University of Liverpool
Summary:
Scientists have found that information about a patient's genes could help increase the effectiveness of drugs such as warfarin.

Scientists at the University of Liverpool have found that information about a patient’s genes could help increase the effectiveness of drugs such as warfarin.

Related Articles


A team of international researchers, which included scientists from Liverpool and Newcastle University, developed a mathematical formula to understand how genetic information about a patient could help clinicians better predict the appropriate dosage of warfarin – one of the world’s most widely prescribed drugs.

Warfarin is used to prevent blood clots that lead to heart attacks, strokes and in extreme cases, death.  The drug is prescribed to one per cent of patients in the UK, but clinicians have found that the appropriate dose of the drug is difficult to predict because individual patients react differently to it.

Scientists developed a model based on administration of fixed drug dosages per day and standard clinical information about individual patients.  They combined this data with additional information on variations in two genes called, CYP2C9 and VKORC1, which differ slightly among individual patients and are known to influence the effectiveness of warfarin.  Researchers then compared their calculations with actual prescribed dosages, and found that by using the additional genetic information they could better predict the optimal warfarin dose for each patient.

Professor Munir Pirmohamed, from the University’s School of Biomedical Sciences, explains: “Warfarin is amongst the top three drugs responsible for hospital-related adverse drug reactions.  It is also, however, highly beneficial in preventing thrombosis and strokes, and we need to develop methods that improve the benefits and minimize the harms associated with the use of the drug.  The crucial issue is to identify the correct dose for each patient.”

Professor Farhad Kamali, from the University of Newcastle, added: “The way different patients respond to warfarin is notoriously unpredictable, particularly at the start of treatment. Now we know that certain genes can affect the way individual patients respond to warfarin, we can use this information to personalise therapy.”

Liverpool and Newcastle will join research centres across Europe in conducting randomised clinical trials of more than 2,000 new patients to better understand if the more precise, gene-based studies are the best option for patients starting drug treatment.  The trial, called EU-PACT, is due to start in October this year and patients will be recruited through doctors in the Liverpool and Newcastle region.

The warfarin studies are supported by the Department of Health. The EU-PACT trial is being supported by the EU FP7 Framework programme.


Story Source:

The above story is based on materials provided by University of Liverpool. Note: Materials may be edited for content and length.


Cite This Page:

University of Liverpool. "Scientists Study Genes To Improve Warfarin Treatment." ScienceDaily. ScienceDaily, 20 February 2009. <www.sciencedaily.com/releases/2009/02/090220075141.htm>.
University of Liverpool. (2009, February 20). Scientists Study Genes To Improve Warfarin Treatment. ScienceDaily. Retrieved October 26, 2014 from www.sciencedaily.com/releases/2009/02/090220075141.htm
University of Liverpool. "Scientists Study Genes To Improve Warfarin Treatment." ScienceDaily. www.sciencedaily.com/releases/2009/02/090220075141.htm (accessed October 26, 2014).

Share This



More Health & Medicine News

Sunday, October 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
Toxin-Packed Stem Cells Used To Kill Cancer

Toxin-Packed Stem Cells Used To Kill Cancer

Newsy (Oct. 25, 2014) — A Harvard University Research Team created genetically engineered stem cells that are able to kill cancer cells, while leaving other cells unharmed. Video provided by Newsy
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins